RenovoRx (RNXT) Institutional Ownership $1.50 +0.09 (+6.38%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for RenovoRx (NASDAQ:RNXT)CurrentInstitutional OwnershipPercentage3.10%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$316.87KNumber ofInstitutional Sellers(last 12 months)0 Get RNXT Insider Trade Alerts Want to know when executives and insiders are buying or selling RenovoRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNXT Institutional Buying and Selling by Quarter RenovoRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC232,937$247K0.0%+61.9%0.971% 2/9/2024Nixon Peabody Trust Co.97,165$223K0.0%N/A0.909% 7/10/2023Level Four Advisory Services LLC15,000$34K0.0%+50.0%0.148% 6/5/2023Level Four Advisory Services LLC10,000$35K0.0%N/A0.099% 1/19/2023 Affinity Capital Advisors LLC15,259$36K0.0%+35.6%0.168% 11/10/2022Cohen Lawrence B54,121$159K0.1%-44.3%0.597% 8/11/2022Cohen Lawrence B97,165$192K0.1%+79.5%1.072% 8/2/2022Bank of The West975,000$1.93M0.2%N/A10.750% 5/13/2022Cohen Lawrence B54,121$159K0.1%N/A0.599% 2/3/2022Cambridge Investment Research Advisors Inc.14,400$70K0.0%-64.7%0.162% 11/16/2021Schonfeld Strategic Advisors LLC20,569$125K0.0%N/A0.245% 11/16/2021Two Sigma Securities LLC17,944$108K0.0%N/A0.214% 11/12/2021Board of Trustees of The Leland Stanford Junior University60,863$368K0.0%N/A0.726% 11/2/2021Cambridge Investment Research Advisors Inc.40,850$247K0.0%N/A0.487% (Data available from 1/1/2016 forward) RNXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNXT shares? During the previous two years, the following institutional investors and hedge funds held shares of RenovoRx shares: Geode Capital Management LLC ($247K), and Nixon Peabody Trust Co. ($223K), Level Four Advisory Services LLC ($34K).Learn more on RNXT's institutional investors. What percentage of RenovoRx stock is owned by institutional investors? 3.10% of RenovoRx stock is owned by institutional investors. Learn more on RNXT's institutional investor holdings. Which institutional investors have been buying RenovoRx stock? The following institutional investors have purchased RenovoRx stock in the last 24 months: Nixon Peabody Trust Co. ($97.17K), Geode Capital Management LLC ($89.02K), and Level Four Advisory Services LLC ($15K). How much institutional buying is happening at RenovoRx? Institutional investors have bought a total of 201,183 shares in the last 24 months. This purchase volume represents approximately $363.02K in transactions. Related Companies TSVT Major Shareholders TIL Major Shareholders ALGS Major Shareholders TNYA Major Shareholders LPTX Major Shareholders XBIT Major Shareholders ATOS Major Shareholders ANRO Major Shareholders TARA Major Shareholders IVA Major Shareholders This page (NASDAQ:RNXT) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
